Importantly, HNSCC cells harboring loss-of-function (LOF) NOTCH1 mutations were more sensitive to PI3K/mTOR inhibition than wild-type counterparts, providing a strong rationale for its clinical development in genetically defined populations [67]. The gene discussed is NOTCH1; the disease is head and neck squamous cell carcinoma.